Scientists use CRISPR to edit structural gene in organism that causes leishmaniasis OHIO STATE UNIVERSITY COLUMBUS, Ohio – Scientists are planning for Phase 1 human trials of a vaccine they developed by using CRISPR gene-editing technology to mutate the parasite that causes leishmaniasis, a skin disease common in tropical regions of the world and gaining...